Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk

BACKGROUND: Response to modern treatment strategies, which combine cytotoxic compounds with immune stimulatory agents and targeted treatment is highly variable among MCL patients. Thus, providing prognostic and predictive markers for risk adapted therapy is warranted and molecular information that c...

Descripción completa

Detalles Bibliográficos
Autores principales: Lokhande, Lavanya, Kuci Emruli, Venera, Kolstad, Arne, Hutchings, Martin, Räty, Riikka, Jerkeman, Mats, Ek, Sara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720632/
https://www.ncbi.nlm.nih.gov/pubmed/33287742
http://dx.doi.org/10.1186/s12885-020-07678-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720632/
https://www.ncbi.nlm.nih.gov/pubmed/33287742
http://dx.doi.org/10.1186/s12885-020-07678-4

Ejemplares similares